a problem with DMPS

[Guest guest]

See below, posted by Theresa Binstock on ABMD. Of course DMPS is not recommended by Andy Cutler and it is not possible therefore for these mainstream doctors to have followed his protocol

>>Actually Andy does recommend DMPS its just that its expensive and you need an Rx, its just IV's of it (or anything else) he has a problem with

Mandi x

[Guest guest]

See below, posted by Theresa Binstock on ABMD. Of course DMPS is not

recommended by Andy Cutler and it is not possible therefore for these

mainstream doctors to have followed his protocol

Sally

*1: *Clin Toxicol (Phila). <javascript:AL_get(this, 'jour', 'Clin

Toxicol (Phila).');> 2008 Jun;46(5):479-81.Click here to read

<http://www.ncbi.nlm.nih.gov/entrez/utils/fref.fcgi?PrId=3079 & itool=AbstractPlus\

-def & uid=18568806 & db=pubmed & url=http://www.informaworld.com/openurl?genre=articl\

e & doi=10.1080/15563650701779687 & magic=pubmed%7C%7C1B69BA326FFE69C3F0A8F227DF8201\

D0>

Links <javascript:PopUpMenu2_Set(Menu18568806);>

s- syndrome in a child with chronic mercury

exposure and 2,3-dimercaptopropane-1-sulfonate (DMPS) therapy.

*Van der Linde AA*

<http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed & Cmd=Search & Term=%22Van%20der\

%20Linde%20AA%22%5BAuthor%5D & itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPa\

nel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus>,

*Pillen S*

<http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed & Cmd=Search & Term=%22Pillen%20\

S%22%5BAuthor%5D & itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_D\

iscoveryPanel.Pubmed_RVAbstractPlus>,

*Gerrits GP*

<http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed & Cmd=Search & Term=%22Gerrits%2\

0GP%22%5BAuthor%5D & itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed\

_DiscoveryPanel.Pubmed_RVAbstractPlus>,

*Bouwes Bavinck JN*

<http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed & Cmd=Search & Term=%22Bouwes%20\

Bavinck%20JN%22%5BAuthor%5D & itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPan\

el.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus>.

Canisius Wilhelmina Hospital, Pediatrics, Nijmegen, Netherlands.

annelieke@...

INTRODUCTION: s- syndrome (SJS) is an uncommon and

potentially serious mucocutaneous disease. The most important step

in the management of SJS is early recognition and immediate

withdrawal of the causative agent. We present a patient with SJS

associated with dimercaptopropane-1-sulfonate (DMPS) therapy. CASE

REPORT: An asymptomatic 11-year old boy who had been exposed

chronically to mercury vapour had a 24-hour urine mercury

concentration of 37 microgram/L (reference value <10 microgram/L).

Exposure to the mercury vapour was stopped and treatment with oral

DMPS was begun. After two weeks of therapy, he developed a

disseminated cutaneous eruption of red pruritic macules on his chest

and back, which three days later had spread all over his body with

the discrete maculae becoming confluent; erosions and crusts

developed on his lips and he had blisters in his mouth. The

diagnosis of SJS was made, the DMPS was stopped, and the SJS

resolved gradually. DISCUSSION: Chelation agents like DMPS or DMSA

are increasingly used and are available over the counter in some

countries. These drugs are used in patients with complaints that are

attributed to mercury-containing dental amalgams and in children

with autism. CONCLUSION: The reported association suggests that SJS

may be a potential complication of DMPS therapy, and this should be

considered in the risk-benefit analysis of chelation. The reported

association suggests that SJS may be a potential complication of

DMPS therapy, and this should be considered in the risk-benefit

analysis of chelation.

PMID: 18568806

No virus found in this incoming message.

Checked by AVG - http://www.avg.com

Version: 8.0.169 / Virus Database: 270.7.0/1683 - Release Date: 21/09/2008 10:10